XML 90 R72.htm IDEA: XBRL DOCUMENT v3.8.0.1
Quarterly Financial Data (Unaudited) - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2015
Quarterly Financial Data [Line Items]                
Royalty and license fee           $ 31,787 $ 33,203 $ 31,763
Acquisition related costs including due diligence and integration expenses             3,187  
Royalty catch-up payment     $ 2,900          
Income tax provision           $ 3,107 $ 6,963 $ 6,294
ASU No. 2016-09 [Member]                
Quarterly Financial Data [Line Items]                
Income tax provision   $ 500            
Out of Period Royalty Adjustment [Member]                
Quarterly Financial Data [Line Items]                
Royalty and license fee       $ 1,100        
Previously Reported [Member]                
Quarterly Financial Data [Line Items]                
Royalty and license fee       $ 1,000        
Creagh Medical and NorMedix [Member]                
Quarterly Financial Data [Line Items]                
Acquisition related costs including due diligence and integration expenses         $ 2,500      
Intellectual Property [Member]                
Quarterly Financial Data [Line Items]                
Royalty and license fee $ 1,100